米Microsoftは10月14日（現地時間）、すべてのサポート中バージョンのWindowsに対し月例のセキュリティ更新プログラムをリリースした（パッチチューズデー）。現在、「Windows Update」や「Windows Update カタログ」などから入手可能。Windows以外の製品も含め、今月 ...

Microsoft has reminded that Exchange Server 2016 and 2019 reached the end of support and advised IT administrators to upgrade servers to Exchange Server SE or migrate to Exchange Online. According to ...

TL;DR: Grab Microsoft Office Pro 2021 for Windows plus a complete Microsoft training bundle for just $39.97 (MSRP: $239.99) — a lifetime license and 25 hours of training in one package. Owning ...

MicrosoftはOffice 2016および2019のユーザーに速やかなアップグレードを推奨している。企業および学校のIT管理者にはMicrosoft 365 AppsまたはOffice LTSC 2024へのアップグレードを提案し、個人ユーザーには次の選択肢を提案している。 Microsoft 365サブスクリプションに ...

Eyeing a drug that it believes holds peak annual sales potential of $12 billion in the U.S. alone, Zenas BioPharma has struck a licensing deal with China-based InnoCare Pharma that could be worth more ...

Microsoft is investigating an ongoing incident that is preventing some customers from accessing Microsoft 365 applications. While the company has yet to share which regions are currently affected by ...

Whether it be for personal expression or practical reasons, Mississippi gives drivers the option of customizing their license plates - but not all applications are accepted. In 2025, four personalized ...

With new features like agent-to-agent collaboration, multi-LLM orchestration, and enterprise-grade governance, Oracle positions its platform as a serious contender in the AI automation race. Oracle ...

Video game streaming is getting larger and more reliable by the year, but does that mean it's on its way to surpassing traditional gaming?

Microsoft MSFT1.98%increase; green up pointing triangle has a lofty goal: to become an artificial-intelligence chatbot powerhouse in its own right rather than leaning on its partnership with the ...

Design and construction companies involved in building schools have more to consider these days than the brick veneer on the ...

After charting several related moves earlier this year, Boehringer Ingelheim is returning to the antibody-drug conjugate well. Boehringer will pay AimedBio up to $991 million to license and develop ...